Monday, June 13, 2016
- 8:30am-8:45am
-
Ledipasvir/Sofosbuvir (LDV/SOF) for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 HCV Infection.
Joint Plenary Session II • Veterans Auditorium
- 8:45am-9:00am
-
Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.
Joint Plenary Session II • Veterans Auditorium
- 9:00am-9:15am
-
Impact on Renal Function of Stepwise Withdrawal of Tacrolimus Combined with Everolimus and EC-MPS vs Standard Treatment Combining Tacrolimus and EC-MPS in De Novo Liver Transplant Recipients: Results of the SIMCER Study.
Joint Plenary Session II • Veterans Auditorium
- 9:15am-9:30am
-
Prevalence of Polyreactive Innate-Like B Cells Among Graft-Infiltrating B Cells in Human Cardiac Allograft Vasculopathy.
Joint Plenary Session II • Veterans Auditorium
- 2:30pm-2:42pm
-
Early Post-Transplant Immunosuppression (IS) Withdrawal – Final Outcomes of the ITN030ST AWISH Study.
- 2:30pm-2:42pm
-
Evaluation of a Novel Global Immunity Assay to Predict Infections in Organ Transplant Recipients.
- 2:30pm-2:42pm
-
Implementation of Telehealth Is Associated with Improved Timeliness of Kidney Transplant Waitlist Evaluation at a VA Center.
- 2:30pm-2:42pm
-
Mining the Human Proteome for Monitoring Renal Transplant Injury.
Concurrent Session: Kidney Immune Monitoring 2 • Ballroom C
- 1
- 2
- 3
- …
- 51
- Next Page»